JP2019516791A5 - - Google Patents

Download PDF

Info

Publication number
JP2019516791A5
JP2019516791A5 JP2019510749A JP2019510749A JP2019516791A5 JP 2019516791 A5 JP2019516791 A5 JP 2019516791A5 JP 2019510749 A JP2019510749 A JP 2019510749A JP 2019510749 A JP2019510749 A JP 2019510749A JP 2019516791 A5 JP2019516791 A5 JP 2019516791A5
Authority
JP
Japan
Prior art keywords
nervous system
combination according
vascular
dementia
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019510749A
Other languages
English (en)
Japanese (ja)
Other versions
JP6997995B2 (ja
JP2019516791A (ja
Filing date
Publication date
Priority claimed from CU2016000059A external-priority patent/CU24576B1/es
Application filed filed Critical
Publication of JP2019516791A publication Critical patent/JP2019516791A/ja
Publication of JP2019516791A5 publication Critical patent/JP2019516791A5/ja
Application granted granted Critical
Publication of JP6997995B2 publication Critical patent/JP6997995B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019510749A 2016-05-04 2017-05-03 中枢神経系及び脈管系障害の治療用のフェノール化合物及び、１，４－ジヒドロピリジンに融着したベンゾジアゼピンとのそれらの組合せ Expired - Fee Related JP6997995B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CUCU-2016-0059 2016-05-04
CU2016000059A CU24576B1 (es) 2016-05-04 2016-05-04 Compuesto fenólico y combinación del mismo con una benzodiazepina fusionada a 1,4-dihidropiridina para el tratamiento de afecciones del sistema nervioso central y vascular
PCT/CU2017/050003 WO2017190714A1 (es) 2016-05-04 2017-05-03 Compuesto fenólico y combinación del mismo con una benzodiazepina fusionada a 1,4-dihidropiridina para el tratamiento de afecciones del sistema nervioso central y vascular

Publications (3)

Publication Number Publication Date
JP2019516791A JP2019516791A (ja) 2019-06-20
JP2019516791A5 true JP2019516791A5 (https=) 2021-05-06
JP6997995B2 JP6997995B2 (ja) 2022-02-04

Family

ID=60202803

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019510749A Expired - Fee Related JP6997995B2 (ja) 2016-05-04 2017-05-03 中枢神経系及び脈管系障害の治療用のフェノール化合物及び、１，４－ジヒドロピリジンに融着したベンゾジアゼピンとのそれらの組合せ

Country Status (19)

Country Link
US (1) US10722491B2 (https=)
EP (1) EP3453704B1 (https=)
JP (1) JP6997995B2 (https=)
KR (1) KR102416478B1 (https=)
CN (1) CN109476627B (https=)
AR (1) AR108370A1 (https=)
AU (1) AU2017259749C1 (https=)
BR (1) BR112018072579B1 (https=)
CA (1) CA3023073C (https=)
CL (1) CL2018003114A1 (https=)
CO (1) CO2018011927A2 (https=)
CU (1) CU24576B1 (https=)
EA (1) EA037951B1 (https=)
ES (1) ES2878579T3 (https=)
MX (1) MX384967B (https=)
PH (1) PH12018502327A1 (https=)
SG (1) SG11201809843SA (https=)
WO (1) WO2017190714A1 (https=)
ZA (1) ZA201808161B (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CU20160058A7 (es) 2016-05-04 2017-12-08 Centro De Investigación Y Desarrollo De Medicamentos (Cidem) Organizacion Superior De Desarrollo Emp Derivado de benzodiazepina con actividad sobre el sistema nervioso central y vascular
US12324567B2 (en) * 2018-10-16 2025-06-10 Saban Ventures Pty Limited Apparatus and method for cleaning a medical device
CU20190114A7 (es) 2019-12-26 2021-08-06 Centro De Investig Y Desarrollo De Medicamentos Cidem Combinación para simultáneamente incrementar la eficacia analgésica de la morfina y reducir su dependencia física
CA3164091A1 (en) * 2019-12-26 2021-07-15 Centro De Investigacion Y Desarrollo De Medicamentos Cidem Use of a benzodiazepine derivative and method of treatment of traumatic brain injury

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5281714A (en) 1990-08-16 1994-01-25 American Home Products Corporation N,N',N'-trisubstituted-5-bisaminomethylene-1,3-dioxane-4,6-dione inhibitors of acyl-CoA: cholesterol-acyl transferase
MX9204939A (es) 1991-09-06 1993-03-01 American Home Prod Inhibidores 5-bis-aminometilen-1,3-dioxan-4,6-diona n,n',n'-trisubstituidas, de la acil coenzima a: colesterol-aciltransferasa.
DK0578849T3 (da) 1992-07-17 1995-09-18 Biogal Gyogyszergyar Fremgangsmåde til fremstilling af 1,3-dioxan-4, 6-dionderivater
JPH11180975A (ja) 1997-10-13 1999-07-06 Chemiprokasei Kaisha Ltd アミノメチレンジオキサン誘導体、その製造方法および用途
CA2558585C (en) 2004-02-27 2010-10-12 Amgen Inc. Compounds, pharmaceutical compositions and methods for use in treating metabolic disorders
JP2007063444A (ja) * 2005-08-31 2007-03-15 Tdk Corp 錯化合物及びこれを用いた光記録媒体

Similar Documents

Publication Publication Date Title
JP2017520613A5 (https=)
JP2017528503A5 (https=)
JP2019524883A5 (https=)
FI3406609T3 (fi) Bisyklisiä atsayhdisteitä muskariinireseptorin agonisteina
JP2019516791A5 (https=)
JP2018035160A5 (https=)
JP2012521994A5 (https=)
JP2015503610A5 (https=)
PH12015501517A1 (en) Pyrimidone derivatives and their use in the treatment, amelioration or prevention of a viral disease
BR112014029006A2 (pt) derivados de 7-oxo-4,7-di-hidro-pirazolo[1,5-a]pirimidina que são úteis no tratamento, melhora ou prevenção de uma doença viral
JP2017504611A5 (https=)
JP2020502092A5 (https=)
JP2017504635A5 (https=)
JP2016503010A5 (https=)
JP2012508734A5 (https=)
JP2016510326A5 (https=)
FI3856341T3 (fi) (s)-1-(4-fluorifenyyli)-1-(2-(4-(6-(1-metyyli-1h-pyratsol-4-yyli)pyrrolo[2,1-f][1,2,4]triatsin-4-yyli)piperatsinyyli)pyrimidin-5-yyli)etaani-1-amiinin kidemuotoja ja valmistusmenetelmiä
JP2018530608A5 (https=)
JP2015500223A5 (https=)
JP2019512533A5 (https=)
JP2017507980A5 (https=)
JP2017520588A5 (https=)
CN115315423A (zh) 取代芳基类化合物
BR112015016184A2 (pt) derivados de piridona e seu uso no tratamento, melhora ou prevenção de uma doença viral
WO2023178111A3 (en) Organic compounds